Advertisement
Advertisement

CSBR

CSBR logo

Champions Oncology, Inc.

5.19
USD
Sponsored
0.00
0.00%
Aug 07, 15:50 UTC -4
Closed
exchange

After-Market

5.20

0.00
+0.10%

Champions Oncology, Inc. Profile

About

Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.

Info & Links

CEO

Robert Brainin

Headquarters

One University Plaza, Suite 307
Hackensack, NJ 07601, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.championsoncology.com

Auditor

EisnerAmper LLP

Share holders

1,900

Employees

214

Champions Oncology, Inc. Statistics

Valuation Measures

Market Capitalization2

72.18M

Enterprise Value

67.31M

Enterprise Value/EBITDA(ttm)

283.99

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.21

Price to Book(mrq)

17.72

Price to Cash(ytd)

356.80

Profitability

Gross Margin(ttm)

48.00%

Operating Margin(ttm)

-1.87%

Profit Margin(ttm)

-2.07%

Return on Equity(ttm)

-27.48%

Return on Invested Capital(ttm)

-30.34%

Return on Assets(ttm)

-3.84%

Income Statement

Revenue(ttm)

59.43M

Revenue Per Share(ttm)

4.28

Gross Profit(ttm)

28.52M

EBITDA(ttm)3

237.00K

Net Income Available to Common(ttm)

-1.18M

Diluted EPS(ttm)

-0.08

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

-15.06%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

13.89M

Dividend Yield

0.00%

Float4

7.37M

% Held by Insiders

46.98%

% Held by Institutions

41.30%

Balance Sheet

Total Cash(mrq)

4.87M

Total Cash Per Share(mrq)

0.35

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.96%

Quick Ratio(mrq)

0.96%

Book Value Per Share(mrq)

0.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.32

Free Cash Flow(ytd)

-5.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement